Safer use of HRT through personalisation
Sly Nedic discusses the ongoing debate concerning the use of conventional HRT and bioidentical HRT, and why personalisation is paramount to increase the safety and efficacy of treatment
Read MorePRIME Journal is part of the Informa Markets Division of Informa PLC
PRIME Journal is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
